Partially hydrolyzed guar gum alleviates small intestinal mucosal damage after massive small bowel resection along with changes in the intestinal microbiota

J Pediatr Surg. 2019 Dec;54(12):2514-2519. doi: 10.1016/j.jpedsurg.2019.08.048. Epub 2019 Sep 2.

Abstract

Purpose: Short bowel syndrome is associated with intestinal mucosal inflammation and microbial dysbiosis, leading to intractable complications. Partially hydrolyzed guar gum (PHGG) has trophic and anti-inflammatory effects on the intestine. We investigated whether PHGG ameliorates small intestinal mucosal damage and alters the intestinal microbiota using a rat small bowel resection (SBR) model.

Methods: Sprague Dawley rats were divided into sham operation (Sham), Sham/PHGG, SBR, and SBR/PHGG groups. On day 21, all rats were euthanized. To assess small intestinal mucosal damage, the degeneration rate was morphometrically evaluated and immunohistochemically examined using anti-CD45 antibodies. Analyses of fecal microbiota using 16S rRNA and short-chain fatty acid production were also performed.

Results: The mucosal degeneration rate was significantly higher in the SBR group than in the Sham or SBR/PHGG groups. The number of CD45-positive cells was significantly higher in the SBR group than in the Sham, Sham/PHGG, or SBR/PHGG groups. The relative abundance of family Lachnospiraceae was significantly higher in the SBR/PHGG group than in the SBR group.

Conclusions: PHGG administration alleviated small intestinal mucosal damage which could be associated with modulation of the intestinal microbiota.

Keywords: Dietary fiber; Dysbosis; Intestinal failure; Partially hydrolyzed guar gum; Short bowel syndrome; Short chain fatty acids.

MeSH terms

  • Animals
  • Fatty Acids, Volatile / metabolism
  • Feces / microbiology
  • Galactans / therapeutic use*
  • Gastrointestinal Microbiome*
  • Inflammation / metabolism
  • Inflammation / prevention & control
  • Intestinal Diseases / etiology
  • Intestinal Diseases / metabolism
  • Intestinal Diseases / pathology
  • Intestinal Diseases / prevention & control*
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / microbiology
  • Intestinal Mucosa / pathology*
  • Intestine, Small / microbiology
  • Intestine, Small / surgery*
  • Leukocyte Common Antigens / metabolism
  • Male
  • Mannans / therapeutic use*
  • Plant Gums / therapeutic use*
  • Postoperative Complications / etiology
  • Postoperative Complications / metabolism
  • Postoperative Complications / pathology
  • Postoperative Complications / prevention & control*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Fatty Acids, Volatile
  • Galactans
  • Mannans
  • Plant Gums
  • guar gum
  • Leukocyte Common Antigens
  • Ptprc protein, rat